SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3999Oops, I spoke too soon. EDGAR's historical archives only go back to 1993. John Metcalf7/25/2004
3998:-) You almost remember the story correctly.... Rathmann called the guy in whscaram(o)uche7/24/2004
3997Yup. It wasn't that long ago when Amgen was the only biotech with a $10B maJohn Metcalf7/23/2004
3996Weak pharma IPO (with a product): 10:39 ET Auxilium Pharma IPO prices below inisjemmeri7/23/2004
3995annualized <i>product</i> revenue, projecting that quarter forward??scaram(o)uche7/22/2004
3994Amgen's Second Quarter 2004 Total Product Sales, Adjusted Earnings and GAAP scaram(o)uche7/22/2004
3993Will do.nigel bates7/22/2004
3992I would be interested in keeping an eye on cyclacel. Nigel, if you could remindkeokalani'nui7/22/2004
3991Cyclacel looks to cash in on IPO to lead biotech revival AFTER a four-year finnigel bates7/22/2004
3990(a) ISSUANCE OF CAPITAL STOCK 1. On March 16, 2001, we sold an aggregate scaram(o)uche7/21/2004
3989Looks like it came out at about 670M. Reasonable valuation IMO, if they executescaram(o)uche7/21/2004
3988Worthless? We'll see. Late, that's certain. Thanks for posting that. scaram(o)uche7/20/2004
3987<i>Pfffffffffffffffffbbbbbbbbbbt!</i> There'll always be a job nigel bates7/20/2004
3986Another worthless macro call? A top performer throws in the towel By Mark HulbeSpekulatius7/20/2004
3985>> baby seal << two demerits. >> baby seal portfolio, and clscaram(o)uche7/19/2004
3984CNBC had a report on Neurochem and the success they are having in Phase II with jayhawk9697/19/2004
3983As you know, the sector gets run back and forth. The upside runs always take moscaram(o)uche7/19/2004
3982>> fan of "mature" companies << Pfffffffffffffffffbbbbbbbscaram(o)uche7/19/2004
3981Another fan of "mature" companies marketwatch.com Picture of health Bhmpa7/18/2004
3980I've been listening to a market wizard [non-biotech] say that the Naz is poiDoc Bones7/18/2004
3979Steve, I believe Phase Forward's symbol is PFWD. Thanks for the info, BobThe Dodgy Ticker7/16/2004
3978Germany's Epigenomics to float on Monday at 9 eur per share BERLIN (AFX) - nigel bates7/16/2004
3977The post-July ASCO crooks have done it again. The delta in capitalizations betwscaram(o)uche7/16/2004
3976Chuckle. Great legs. Four of 'em. (eom)scaram(o)uche7/16/2004
3975"...knockout mice as well as other organisms such as fruit flies, worms andLance Bredvold7/16/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News